Kura Oncology, Inc. Share Price & Technical Analysis
KURA · $10.41 (-7.47%)
Healthcare / Biotechnology
$10.41
-7.47%
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapie…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
27% return in May, 10% avg return in past 3 year May month.
16% return in 2026, 9% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -22% | 7% | -5% | 9% | 27% | – | – | – | – | – | – | – | 16% |
| 25 | -10% | 0% | -15% | 0% | -12% | -2% | 5% | 32% | 11% | 16% | 19% | -13% | 30% |
| 24 | 39% | 3% | 1% | -8% | 5% | -2% | 1% | 4% | -7% | -14% | -34% | -22% | -34% |
| 23 | 10% | -15% | 3% | -20% | 37% | -21% | -2% | -5% | -8% | -9% | 13% | 48% | 31% |
| 22 | -1% | 14% | 1% | -11% | -8% | 38% | -17% | -9% | -1% | 12% | 0% | -22% | -5% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Strong · Uptrend
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$856.56M
P/E ratio
—
52W high
$12.49
52W low
$5.45
Volume
29,08,784
Beta
0.32
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Kura Oncology, Inc. share price today?
- Kura Oncology, Inc. (KURA) last traded around $10.41 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does KURA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for KURA. Download the app for real-time alerts.
- How can I analyze Kura Oncology, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.